Comparison of standard triple therapy, sequential therapy and moxifloxacin‐based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates

By  

Journal of Digestive Diseases, Vol. 15, Iss. 9, 2014-09 ,pp. : 508-513

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evolving therapy for Helicobacter pylori infection

By Zullo Angelo   Hassan Cesare   Campo Salvatore MA   Morini Sergio  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1453-1464

Informa Healthcare

Access to resources Recommend Favorite

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

By Shirai Naohito   Sugimoto Mitsushige   Kodaira Chise   Nishino Masafumi   Ikuma Mutsuhiro   Kajimura Masayoshi   Ohashi Kyoichi   Ishizaki Takashi   Hishida Akira   Furuta Takahisa  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 8, 2007-08 ,pp. : 743-749

Springer Publishing Company

Access to resources Recommend Favorite

Helicobacter pylori Infection and Eradication in Paediatric Patients

By Malaty H.M.  

Pediatric Drugs, Vol. 2, Iss. 5, 2000-09 ,pp. : 357-365

Adis International

Access to resources Recommend Favorite

A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

By Boer Wink A de  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1559-1566

Informa Healthcare

Access to resources Recommend Favorite